Page last updated: 2024-09-04

atrasentan and Atherogenesis

atrasentan has been researched along with Atherogenesis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gulati, R; Lennon, R; Lerman, A; Lerman, LO; Mario, G; Reriani, M; Rihal, C; Tilford, JM; Yoon, MH	1

Trials

1 trial(s) available for atrasentan and Atherogenesis

Article	Year
Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis. International journal of cardiology, 2013, Sep-30, Volume: 168, Issue:2 Topics: Adult; Atherosclerosis; Atrasentan; Disease Progression; Double-Blind Method; Early Diagnosis; Endothelin A Receptor Antagonists; Female; Follow-Up Studies; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Pyrrolidines; Receptor, Endothelin A; Time Factors	2013

Article

Year

Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis.

International journal of cardiology, 2013, Sep-30, Volume: 168, Issue:2

Topics: Adult; Atherosclerosis; Atrasentan; Disease Progression; Double-Blind Method; Early Diagnosis; Endothelin A Receptor Antagonists; Female; Follow-Up Studies; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Pyrrolidines; Receptor, Endothelin A; Time Factors

2013